As of April 2024 Genscript Biotech has a market cap of $2.99 Billion. This makes Genscript Biotech the world's 3442th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.99 B | -44.61% |
2023 | $5.39 B | -19.94% |
2022 | $6.74 B | -27.46% |
2021 | $9.29 B | 228.28% |
2020 | $2.83 B | -33.66% |
2019 | $4.26 B | 72.48% |
2018 | $2.47 B | -43.8% |
2017 | $4.40 B | 452.98% |
2016 | $0.79 B | 192.28% |
2015 | $0.27 B |
On Apr 26th, 2024 the market cap of Genscript Biotech was reported to be: